Estimating Health State Utilities for Patients with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) and Systemic Anaplastic Large-Cell Lymphoma (sALCL) in Mexico and Brazil
Abstract
Authors
S. Shingler P. Swinburn A. Lloyd V. Bonthapally